MedTrace Logo

Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors

NCT04281953 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-03-25

No results posted yet for this study

Summary

This project aims to explore, in depth, the burden of hearing loss and tinnitus on cancer survivors. Using semi-structured interviews, audiograms and a variety of validated questionnaires, the specific impact ototoxicity has on quality of life will be investigated.

From this, we can identify the specific needs of patients experiencing hearing loss and tinnitus following chemotherapy and develop a tailored and personalised support system.

Conditions

  • Quality of Life
  • Cancer
  • Hearing Loss, Sensorineural
  • Tinnitus, Subjective
  • Late Effect

Interventions

DIAGNOSTIC_TEST

High frequency audiometry

Simple hearing test

OTHER

Short-Form 36-Item Questionnaire (SF-36)

Questionnaire on quality of life (Short Form 36 Item- SF-36)

OTHER

Hearing handicap inventory for adults/elderly (HHIA/HHIE)

Questionnaire on Hearing loss (Hearing handicap inventory for adults/elderly- HHIA/HHIE)

OTHER

Tinnitus handicap inventory (THI)

Questionnaire on Tinnitus (Tinnitus Handicap Inventory)

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • International Stem Cell Forum

    collaborator OTHER

  • University of Nottingham

    lead OTHER

Principal Investigators

  • David Baguley, PhD · University of Nottingham

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-05
Primary Completion
2020-02-28
Completion
2020-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04281953 on ClinicalTrials.gov